Investing
Investing Cash Flow
Biogen Investing Cash Flow increased by 83.0% to -$209.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 342.9%, from -$47.30M to -$209.50M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 24.9% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
Detailed definition
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Peer comparison
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
Metric ID:
net_cash_from_investingHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$152.70M | -$233.60M | -$112.70M | -$648.00M | $693.50M | $1.67B | $0.00 | -$953.00M | -$753.50M | -$1.74B | -$652.30M | -$66.00M | $466.50M | -$1.18B | -$18.60M | -$47.30M | -$57.00M | -$35.10M | -$1.23B | -$209.50M |
| QoQ Change | — | -53.0% | +51.8% | -475.0% | +207.0% | +141.1% | -100.0% | — | +20.9% | -131.2% | +62.6% | +89.9% | +806.8% | -353.2% | +98.4% | -154.3% | -20.5% | +38.4% | <-999% | +83.0% |
| YoY Change | — | — | — | — | +554.2% | +815.8% | +100.0% | -47.1% | -208.7% | -204.2% | — | +93.1% | +161.9% | +32.2% | +97.1% | +28.3% | -112.2% | +97.0% | <-999% | -342.9% |
Range-$1.74B – $1.67B
CAGR+6.9%
Avg YoY Growth-363.8%
Median YoY Growth+32.2%
Investing Cash Flow at Other Companies
Frequently Asked Questions
- What is Biogen's investing cash flow?
- Biogen (BIIB) reported investing cash flow of -$209.50M in Q1 2026.
- How has Biogen's investing cash flow changed year-over-year?
- Biogen's investing cash flow decreased by 342.9% year-over-year, from -$47.30M to -$209.50M.
- What is the long-term trend for Biogen's investing cash flow?
- Over 4 years (2021 to 2025), Biogen's investing cash flow has grown at a 24.9% compound annual growth rate (CAGR), from -$563.70M to -$1.37B.
- What does investing cash flow mean?
- The net amount of cash spent on or received from investing activities.